期刊文献+

某三级甲等医院干预前后住院患者的抗菌药物使用强度分析 被引量:9

Analysis of Antibiotics Use Density in a Third-grade Class-A Hospital before and after Intervention
原文传递
导出
摘要 目的:了解某三级甲等医院开展抗菌药物临床应用专项整治活动前、后住院患者抗菌药物使用强度(AUD)的变化情况。方法:回顾性调查该院2010年12月-2011年5月(整治前)和2011年6-11月(整治后)住院患者抗菌药物的使用品种、品规,计算其AUD,并进行对比分析。结果:整治后该院抗菌药物品种、品规从整治前的75种、144个分别下降至48种、79个;抗菌药物的AUD由整治前的85.6DDDs/100人/天下降为56.8DDDs/100人/天;静脉用药的AUD由整治前的73.3DDDs/100人/天下降至49.4DDDs/100人/天;排序前10位药品的AUD由整治前的54.0DDDs/100人/天下降至44.5DDDs/100人/天。结论:通过开展抗菌药物临床应用专项整治活动,抗菌药物的AUD、品种、品规降幅较大,但抗菌药物特别是β-内酰胺类复方制剂的AUD仍较高,还须进一步加强干预和控制抗菌药物的使用。 OBJECTIVE: To understand the change of antibiotics use density (AUD) in the inpatients of a third-grade class-A hospital before and after intervention. METHODS: The utilization of antibiotics in the hospital during Dec. 2010- May 2011 (be- fore intervention) and Jun. 2011- Nov. 2011 (after intervention) was analyzed retrospectively in terms of varieties and specifica- tion. RESULTS: After intervention, the varieties and specification of antibiotics decreased from 75 varieties and 144 kinds to 48 va- rieties and 79 kinds; AUD of antibiotics decreased from 85.6 DDDs/100 persons/day to 56.8 DDDs/100 persons/day; AUD of intra- venous administration decreased from 73.3 DDDs/100 persons/day to 49.4 DDDs/100 persons/day; AUD of top 10 drugs decreased from 54.0 DDDs/100 persons/day to 44.5 DDDs/100 persons/day. CONCLUSION: Through developing special rectification of clini- cal use of antibiotics, the AUD, types and specification of antibiotics show great change, but AUD of Compound β-lactam still high, we should further intervene in and control use of antibiotics.
出处 《中国药房》 CAS CSCD 2012年第38期3572-3574,共3页 China Pharmacy
关键词 抗菌药物 使用强度 分析 抗菌药物临床应用专项整治 Antibiotics AUD Analysis Special rectification of clinical use of antibiotics
  • 相关文献

参考文献6

  • 1卫生部办公厅.关于做好全国抗茵药物临床应用专项整治活动的通知[S].卫办医政发[2011]56号.
  • 2杜德才,周书明,沈爱宗,姜玲.医院抗菌药物使用强度分析[J].中华医院感染学杂志,2010,20(6):848-851. 被引量:140
  • 3卫生部,国家中医药管理局,总后卫生部.抗茵药物临床应用指导原则[S].卫医发[2004]285号.
  • 4卫生部办公厅.关于抗茵药物临床应用管理有关问题的通知[s].卫办医政发[2009]38号.
  • 5Yoshida J, Akagi K, Ishimaru T, et al. Drug resistance of pseudomonas aeruginosa in four community hospitals: influence of antimicrobial use density[J]. Jpn J Antibiot, 2011,64(4) :247.
  • 6张瑞丽,李国辉,赵志刚.抗菌药物的序贯疗法及其应用[J].药品评价,2010(22):19-23. 被引量:10

二级参考文献26

共引文献189

同被引文献75

  • 1卢才义,王士雯,赵玉生,魏璇,黄从春,薛桥,晏沐阳,刘玲玲,李玉峰,施伟伟,张文莉.肺部感染与老年多器官功能衰竭的研究[J].中国实用内科杂志:临床前沿版,2006,26(2):259-261. 被引量:23
  • 2陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 3卫生部,国家中医药管理局,总后卫生部.抗菌药物临床应用指导原则[S],卫医发[2004]285号.2004,8.19.
  • 4Assiot M, Gendrel D, Carsin H, et al. High serum procalci- tonin concentrations in patients with sepsis and infection[J]. Lancet, 1993,341 (8844) :515-518.
  • 5Sehuttrumpf S, Binder L, Hagemann T,et al. Utility of pro- calcitonin concentration in the evaluation of patients with ma- lignant diseases and elevated C-reactive protein plasma con- centrations [ M ]. CID, 2006.43.
  • 6卫生部办公厅.2011年全国抗菌药物临床应用专项整治活动方案[Z].卫办医政[2011]56号.2011.
  • 7Maruna P, Nedelnikova K, Gurlieh R. Physiology and ge- netics of Procalcitonin [J]. Physiol Res,2000, 49 (Suppl. 1) :S57-S61.
  • 8Christ-Crain M, Muller B. Biomarkers in respiratory tract infections:diagnostic guides to antibiotic prescription prog- nostic markers and mediators [ J ]. Eur Respir J, 2007, 30 (3) :556-573.
  • 9卫生部办公厅.关于继续深入开展全国抗茵药物临床应用专项整治活动的通知[S].2012-03-05.
  • 10Yoshida J,Akagi K,Ishimaru T,et al. Drug resistance of pseudomonas aeruginosa in four community hospitals:in- fluence of antimicrobial use density[J]. Jpn J Antibiot, 2011,64(4) :247-253.

引证文献9

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部